|
Inpatient
(n=171) |
Outpatient
(n=55) |
Total (n=227) |
P value |
| At least one unexpected or extended hospitalization |
57 (33%) |
10 (18%) |
67 (30%) |
0.034 |
| Because of nephrotoxicity |
10 (6%) |
4 (7%) |
4 (6%) |
0.749 |
| At least one delayed or cancelled cisplatin course |
50 (29%) |
19 (35%) |
69 (30%) |
0.442 |
| Because of nephrotoxicity |
4 (2%) |
4 (7%) |
8 (4%) |
0.1 |
| At least one dose reduction in cisplatin |
67 (39%) |
9 (16%) |
76 (33%) |
0.002 |
| Because of nephrotoxicity |
32 (19%) |
4 (7%) |
36 (16%) |
0.045 |
| Unexpected cisplatin regimen final stop |
85 (49%) |
26 (47%) |
111 (49%) |
0.877 |
| Because of nephrotoxicity |
26 (15%) |
5 (9%) |
31 (14%) |
0.257 |
| At least one nausea and vomiting ≥ CTC grade 2 |
23 (13%) |
7 (13%) |
30 (13%) |
0.902 |
